Centene Corp (CNC) 69.47 $CNC Centene beats 2Q profit

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Centene Corp (CNC) 69.47 $CNC

Centene beats 2Q profit forecasts
Automated Insights - Tue Jul 28, 5:18AM CDT
ST LOUIS (AP) _ Centene Corp. (CNC) on Tuesday reported second-quarter earnings of $88 million.
CNC: 69.47 (+0.37)

Centene Corporation Reports 2015 Second Quarter Results
PR Newswire - Tue Jul 28, 5:00AM CDT
Centene Corporation (NYSE: CNC) today announced its financial results for the quarter ended June 30, 2015. The following discussions, with the exception of cash flow information, are in the context of continuing operations.
CNC: 69.47 (+0.37)

Upgrade Alert for Centene (CNC)
Comtex SmarTrend(R) - Mon Jul 27, 8:04AM CDT
Centene (NYSE:CNC) was upgraded from Neutral to Buy at UBS today. The stock closed yesterday at $69.04 on volume of 1.8 million shares, below average daily volume of 2.2 million. In the past 52 weeks, shares of Centene have traded between a low of $35.49 and a high of $83.00 and closed yesterday at $69.04, which is 95% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 1.3% while the 50-day MA has advanced 0.7%.
CNC: 69.47 (+0.37)

Anthem To Buy Cigna As Insurers Rush To Consolidate
at Investor's Business Daily - Fri Jul 24, 7:34AM CDT
Anthem (ANTM) confirmed Friday that it will buy Cigna (CI) for $48 billion, as the health care industry continues its recent consolidation. Anthem will pay $188 a share, with Cigna shareholders receiving $103.40 in cash and 0.5152 Anthem shares for...
CNC: 69.47 (+0.37), CI: 145.91 (+0.01), ANTM: 154.17 (+2.67), UNH: 121.19 (+3.31), AET: 111.17 (+0.94), HNT: 66.00 (+0.40), HUM: 184.31 (+0.40)

And Then There Were 3? Anthem Near $48 Bil Cigna Deal
at Investor's Business Daily - Wed Jul 22, 10:27PM CDT
Anthem (ANTM) will announce a deal to buy Cigna (CI) for about $48 billion, or $187 a share as soon as Thursday, according to a variety of reports. Along with other mergers, the managed care industry on the road to shrinking to three giants from five...
CNC: 69.47 (+0.37), CI: 145.91 (+0.01), ANTM: 154.17 (+2.67), UNH: 121.19 (+3.31), AET: 111.17 (+0.94), HNT: 66.00 (+0.40), HUM: 184.31 (+0.40)

Humana (HUM) Boosts ACO Relationship with Iora Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 22, 1:35PM CDT
In an attempt to strengthen their Accountable Care arrangement, Humana, Inc. (HUM) and Iora Health will establish seven primary care practices in four markets across Arizona, Colorado and Washington.
CNC: 69.47 (+0.37), ANTM: 154.17 (+2.67), SEM: 14.90 (+0.10), HUM: 184.31 (+0.40)

Molina Scoffs At Merger Mania, Keeps Growing Medicaid
at Investor's Business Daily - Wed Jul 22, 12:58PM CDT
As consolidation fever grips the managed care industry, Molina Healthcare (MOH) prefers to "stick to our knitting," as chief financial officer John Molina likes to say. Its knitting since its founding in 1980 by Molina's father, David Molina, has...
CNC: 69.47 (+0.37), ANTM: 154.17 (+2.67), UNH: 121.19 (+3.31), WCG: 78.63 (+0.52), AET: 111.17 (+0.94), HNT: 66.00 (+0.40), MOH: 68.34 (-0.08), HUM: 184.31 (+0.40)

Downgrade Alert for Centene (CNC)
Comtex SmarTrend(R) - Wed Jul 22, 7:29AM CDT
Centene (NYSE:CNC) was downgraded from Neutral to Sell at Goldman Sachs today. The stock closed yesterday at $71.78 on volume of 2.4 million shares, above average daily volume of 2.1 million. Centene (NYSE:CNC) has potential upside of 5.5% based on a current price of $71.78 and analysts' consensus price target of $75.75. Centene shares should encounter resistance at the 50-day moving average (MA) of $73.98 and support at its 200-day MA of $60.48.
CNC: 69.47 (+0.37)

After Yesterday's Decline of 3.78%, Centene Offers Investors Better Value
Comtex SmarTrend(R) - Tue Jul 21, 4:33PM CDT
Centene (NYSE:CNC) traded in a range yesterday that spanned from a low of $70.50 to a high of $72.85. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $73.25 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CNC: 69.47 (+0.37)

Stocks Hit By Weak Earnings; Tesla, Auto Stocks Fall
at Investor's Business Daily - Tue Jul 21, 3:22PM CDT
Stocks fell Tuesday, ending three sessions of broad-based gains, following weak earnings reports from market heavyweights IBM (IBM) and United Technologies (UTX). The Dow Jones industrial average dropped 1.0% as United Technologies and IBM lost 7%...
LAD: 113.63 (+0.56), TSLA: 264.50 (+11.49), HOG: 58.31 (+0.51), UTX: 98.85 (-0.02), PAG: 50.30 (+0.88), CNC: 69.47 (+0.37), KMX: 62.64 (+0.68), IBM: 160.04 (+0.97), ABG: 84.01 (+0.88), AN: 60.31 (+1.05)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Health Net, Inc. Regarding the Sale of the Company to Centene Corporation
Business Wire - Mon Jul 20, 4:20PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Health Net, Inc. (NYSE:HNT) ("Health Net" or "the Company" in connection with the sale of the Company to Centene Corporation (NYSE:CNC). Under the terms of the transaction, Health Net shareholders will receive 0.622 shares of Centene common stock and $28.25 in cash for each share of Health Net common stock they own.
CNC: 69.47 (+0.37), HNT: 66.00 (+0.40)

Newfound Market Strength Could Benefit These IBD 50 Names
at Investor's Business Daily - Fri Jul 17, 5:48PM CDT
The stock market often does what's least expected, and that certainly has been the case lately. Consider these four recent occurrences: A heavy distribution-day count for the Nasdaq and S&P 500 in recent weeks didn't do much damage to the market. In...
CNC: 69.47 (+0.37), AMBA: 121.15 (+1.70), MNST: 149.43 (+0.67), VRX: 258.12 (+0.82), ILMN: 217.79 (+0.52), RCPT: 227.90 (+0.81), HAWK: 44.11 (+0.56), FLTX: 47.49 (+0.64), REGN: 556.34 (+16.31), CELG: 135.72 (+3.16)

Bigger Is Better For Managed Care In ObamaCare Era
at Investor's Business Daily - Fri Jul 17, 3:02PM CDT
The Supreme Court's June 25 ruling to preserve ObamaCare exchange subsidies in 34 states using HealthCare.gov had the effect of a starter's pistol, shifting insurer consolidation into high gear. The immediate stakes in the case weren't dramatic for...
CI: 145.91 (+0.01), CNC: 69.47 (+0.37), ANTM: 154.17 (+2.67), CTRX: 61.47 (+0.04), UNH: 121.19 (+3.31), CVS: 111.71 (+1.94), AET: 111.17 (+0.94), HNT: 66.00 (+0.40), HUM: 184.31 (+0.40)


UnitedHealth tops Street 2Q forecasts, raises forecasts
By TOM MURPHY - AP - Thu Jul 16, 10:43AM CDT
UnitedHealth continued to juice up its business outside health insurance in a better-than-expected second quarter while rivals scrambled to add enrollment in a wave of mega-mergers sweeping the sector.
CNC: 69.47 (+0.37), CI: 145.91 (+0.01), ANTM: 154.17 (+2.67), CTRX: 61.47 (+0.04), ANTX: 50.67 (+0.39), UNH: 121.19 (+3.31), CCT.TO: 80.18 (+0.12), AET: 111.17 (+0.94), HUM: 184.31 (+0.40)

UnitedHealth Beats Q2 Earnings & Revenues; Raises Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 16, 9:30AM CDT
UnitedHealth's (UNH) reported second-quarter 2015 earnings of $1.64 per share, beating the Zacks Consensus Estimate of $1.57. Earnings soared 15.5% year over year.
CNC: 69.47 (+0.37), ANTM: 154.17 (+2.67), UNH: 121.19 (+3.31), SEM: 14.90 (+0.10)

Molina Healthcare Unit to Buy Medicaid Assets from Preferred - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 15, 4:00PM CDT
Molina Healthcare, Inc. (MOH) has entered into an agreement with Preferred Medical Plan, Inc. (Preferred) pertaining to the acquisition of certain assets of the latter.
CNC: 69.47 (+0.37), ANTM: 154.17 (+2.67), UNH: 121.19 (+3.31), MOH: 68.34 (-0.08)

2 Health Insurers Promising Earnings Beat in Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 15, 3:45PM CDT
The second quarter of 2015 saw frenzied mergers in the health insurance industry with players snapping up rivals to grow and remain competitive in a fast changing landscape.
CNC: 69.47 (+0.37), CI: 145.91 (+0.01), ANTM: 154.17 (+2.67), AET: 111.17 (+0.94), HNT: 66.00 (+0.40), HUM: 184.31 (+0.40)

The Zacks Analyst Blog Highlights: Echo Global Logistics, Centene, Garrison Capital, American Eagle Outfitters and PACCAR - Press Releases
Zacks Equity Research - Zacks Investment Research - Wed Jul 15, 8:30AM CDT
The Zacks Analyst Blog Highlights: Echo Global Logistics, Centene, Garrison Capital, American Eagle Outfitters and PACCAR
CNC: 69.47 (+0.37), ECHO: 31.12 (+0.70), PCAR: 64.57 (-0.08), AEO: 17.63 (-0.15), GARS: 14.76 (-0.15)

Centene (CNC) Stock Upgraded at Jefferies
at The Street - Wed Jul 15, 8:18AM CDT
Centene (CNC) stock was upgraded by analysts at Jefferies to 'buy' from 'hold' and its price target increased to $88 from $75.
CNC: 69.47 (+0.37)

What Could Hurt Q2 Earnings? 5 Profitable Picks - Analyst Blog
Swarup Gupta - Zacks Investment Research - Tue Jul 14, 9:03AM CDT
Second quarter earnings are expected to come in below par and may be plagued by a strong dollar and weak oil prices.
CNC: 69.47 (+0.37), ECHO: 31.12 (+0.70), PCAR: 64.57 (-0.08), AEO: 17.63 (-0.15), GARS: 14.76 (-0.15)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 244

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 385

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 309

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 322

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 324

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 393

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 273

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 234

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 430

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading

Top 5 Most Recently Viewed Articles

Banco Comercial Português Highlights Positive Share Buy-Back Activities

Updated Category News Views 137

Banco Comercial Português: An Overview of Recent Developments Banco Comercial Português, S.A., recognized for its pivotal role in the financial sector, has recently shared insights about its Share Buy-Back Programme. This initiative reflects the bank's commitment to enhancing shareholder value while solidifying its market presence. The interim report detailing the...

Continue Reading
How a $1000 Investment in Texas Instruments Transforms Over 15 Years

Updated Category News Views 135

Understanding the Growth of Texas Instruments Investments Texas Instruments (NASDAQ: TXN) has displayed impressive growth over the past 15 years, outpacing the market by an average of 2.3% annually. This translates to a robust average annual return of 14.17%, reflecting this company's strong position in the semiconductor industry. With a market capitalization now standing...

Continue Reading
Bitdeer Technologies Group's Q4 2024 Financial Overview

Updated Category News Views 204

Bitdeer Technologies Group's Financial Results Analysis Bitdeer Technologies Group (NASDAQ: BTDR), a prominent player in blockchain technology and high-performance computing, has recently unveiled its unaudited financial results for the final quarter of 2024. The announcement sheds light on the company's performance, revealing significant shifts in revenue and expenses...

Continue Reading
NodeAI Revolutionizes Lung Cancer Care with AI Solutions

Updated Category News Views 206

NodeAI's Groundbreaking Achievement in Cancer Diagnostics NodeAI, a pioneering startup based in Hamilton, Ontario, has recently garnered attention for its exceptional advancements in lung cancer diagnostics. The company participated in FACIT's annual pitch competition, known as Falcons' Fortunes, and emerged victorious, earning a prestigious award for its innovative...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 72

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading